Given Jiangsu Nhwa Pharmaceutical's significant investment a...
Given Jiangsu Nhwa Pharmaceutical's significant investment and lucrative return rate, earnings are projected to rise substantially. Despite uncertainty in analysts' projections, performance is deemed satisfactory, fueling expectations for accelerated earnings growth due to low payout ratios.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000017943f653ba776.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment